Piper Sandler Maintains Overweight on Ardelyx, Maintains $15 Price Target
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Christopher Raymond maintains an Overweight rating on Ardelyx (NASDAQ: ARDX) and keeps the price target at $15.
May 24, 2024 | 4:28 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Piper Sandler analyst Christopher Raymond maintains an Overweight rating on Ardelyx (NASDAQ: ARDX) and keeps the price target at $15.
The reaffirmation of an Overweight rating and a $15 price target by a reputable analyst can boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100